NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 3 filers reported holding NEOGENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,230 | -23.5% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $1,607 | -7.7% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $1,741 | +88.4% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $924 | -7.6% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 100 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $3,000 | -40.0% | 100 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | -54.5% | 100 | -50.0% | 0.00% | -50.0% |
| Q4 2020 | $11,000 | +37.5% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $8,000 | +14.3% | 200 | 0.0% | 0.00% | +33.3% |
| Q2 2020 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | -25.0% |
| Q1 2020 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,291,019 | $22,477 | 12.11% |
| Greenhouse Funds LLLP | 2,930,014 | $51,011,544 | 4.27% |
| First Light Asset Management, LLC | 2,698,958 | $46,988,859 | 4.23% |
| PERKINS CAPITAL MANAGEMENT INC | 197,000 | $3,430 | 3.23% |
| Altium Capital Management LP | 240,000 | $4,178,400 | 2.32% |
| FORMULA GROWTH LTD | 280,690 | $4,886,813 | 1.57% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 101,065 | $1,759,542 | 1.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,374,783 | $23,934,972 | 1.41% |
| EMERALD ADVISERS, LLC | 1,669,324 | $29,062,931 | 1.39% |
| Lisanti Capital Growth, LLC | 528,235 | $9,196,571 | 1.28% |